A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk

When performing magnetic resonance imaging image fusion transperineal prostate biopsies there is limited benefit in adding nontargeted prostate biopsy cores owing to a low yield of clinically significant prostate cancer and a higher yield of clinically insignificant cancer.